DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets.
Ontology highlight
ABSTRACT: The druggability of targets is a crucial consideration in drug target selection. Here, we adopt a stochastic semi-supervised ML framework to develop DrugnomeAI, which estimates the druggability likelihood for every protein-coding gene in the human exome. DrugnomeAI integrates gene-level properties from 15 sources resulting in 324 features. The tool generates exome-wide predictions based on labelled sets of known drug targets (median AUC: 0.97), highlighting features from protein-protein interaction networks as top predictors. DrugnomeAI provides generic as well as specialised models stratified by disease type or drug therapeutic modality. The top-ranking DrugnomeAI genes were significantly enriched for genes previously selected for clinical development programs (p value < 1 × 10-308</
SUBMITTER: Raies A
PROVIDER: S-EPMC9700683 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA